Showing 1 - 7 results of 7 for search 'Anna N. Fetisova', query time: 0.02s Refine Results
  1. 1
    Switching to a Second TNF-α Inhibitor in a Patient with Severe Juvenile Polyarthritis: A Clinical Case

    Switching to a Second TNF-α Inhibitor in a Patient with Severe Juvenile Polyarthritis: A Clinical Case by Ekaterina V. Denisova, Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Margarita A. Soloshenko, Anna V. Mamutova, Kseniya B. Isayeva, Anna N. Fetisova

    Published 2018-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Effect of Monotherapy with Methotrexate, Etanercept and their Combination on the Quality of Life in Children with Early and Late Juvenile Idiopathic Arthritis: A Prospective Study

    Effect of Monotherapy with Methotrexate, Etanercept and their Combination on the Quality of Life in Children with Early and Late Juvenile Idiopathic Arthritis: A Prospective Study by Anna N. Fetisova, Tatyana M. Dvoryakovskaya, Vladislav V. Chernikov, Irina V. Vinyarskaya, Rina V. Denisova, Margarita A. Soloshenko, Ksenia В. Isaeva, Anna V. Mamutova

    Published 2018-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

    Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study by Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova

    Published 2019-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    EFFICACY AND SAFETY OF ETANERCEPT TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS. THE RESULTS OF AN OPEN PROSPECTIVE STUDY ON THE BASIS OF THE SCIENTIFIC CENTER OF CHILDREN'S HEALTH (MOSCOW)

    EFFICACY AND SAFETY OF ETANERCEPT TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS. THE RESULTS OF AN OPEN PROSPECTIVE STUDY ON THE BASIS OF... by Ekaterina I. Alekseeva, Тatyana М. Bzarova, Saniya I. Valieva, Rina V. Denisova, Kseniya B. Isaeva, Evgenia G. Chistyakova, Alexandra M. Chomahidze, Tatyana V. Sleptsova, Anna N. Fetisova, Оlga L. Lomakina, Nikolay I. Taybulatov, Anna V. Karaseva

    Published 2016-11-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PROGNOSTIC FACTORS FOR THE RESPONSE TO TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS: A COHORT STUDY

    PROGNOSTIC FACTORS FOR THE RESPONSE TO TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS: A COHORT STUDY by Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova

    Published 2018-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study

    Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study by Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Yuri M. Dyakonov, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova

    Published 2018-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study

    Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic... by Ekaterina I. Alexeeva, Dariya D. Vankova, Tatyana M. Dvoryakovskaya, Ksenia B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomakhidze, Tatyana V. Radygina, Irina V. Zubkova, Natalia E. Tkachenko, Anna N. Fetisova, Olga L. Lomakina, Yanina O. Orlova, Mariya K. Kurdup, Marina S. Gautier, Elizaveta A. Krekhova, Meyri S. Shingarova, Olga P. Galkina

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: